Idiopathic sudden sensorineural hearing loss
Conditions
Interventions
experimental group:Acupuncture, once a day, for 1 week. Ginkgo diterpene lactone gluconate injection, intravenous injection, 5ml each time, once a day, for 7 consecutive days
Prednisolone sodium succinate for injection, intravenous injection, 120mg daily on days 1-3, 80mg daily on days 4-6, 40mg daily on day 7
Mecobalamin injection, intravenous push, 0.5mg each time, for 7 consecutive days. One week later, take Mecobalamin tablets orally, three times a day, 1 tablet each time, for 2 consecutive weeks.
control group:Ginkgo diterpene lactone gluconate injection: Intravenous injection, 5 ml each time, once a day, for 7 consecutive days
Methylprednisolone sodium succinate for injection: Intravenous injection, 120 mg daily on days 1-3, 80 mg daily on days 4-6, 40 mg daily on day 7
Mecobalamin injection: Intramuscular injection, 0.5 mg each time, for 7 consecutive days. One week later, take mecobalamin tablets orally, 1 tablet each time, 3 times a day, for 2 consecutive weeks.
Sponsors
Zhangjiagang City Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Ages 18 to 65; Meets the diagnostic criteria for unilateral sudden sensorineural hearing loss (SSNHL); Time from onset of symptoms to enrollment does not exceed 14 days; Capable of completing audiological assessments, questionnaire evaluations, and signing an informed consent form.
Exclusion criteria
Exclusion criteria: Bilateral sensorineural hearing loss; Known causative hearing loss conditions, such as Meniere's disease, acoustic neuroma, middle ear diseases, noise damage or ototoxic drug-induced deafness; Severe heart, liver, kidney, mental or coagulation dysfunction; Pregnancy or lactation; Recent regular use of potent sedative-hypnotic drugs that may significantly affect sleep assessment; Night shift or long-term shift workers; Those who have received acupuncture treatment within the last 1 month; Those who are unable to complete treatment or follow-up as per the plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pure tone test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tinnitus matching;Speech recognition rate in noise;Tinnitus Disorder Scale;36 Short Health Questionnaires;Pittsburgh Sleep Quality Index Questionnaire;self-rating anxiety scale;insomnia severity index; | — |
Countries
China
Contacts
Public ContactJiang Xiaoting
Zhangjiagang City Traditional Chinese Medicine Hospital
Outcome results
None listed